As the worst flu season in a decade rages on, a potentially groundbreaking new drug that can kill the flu virus in just one day has won regulatory approval—in Japan. Japanese officials granted an accelerated approval to the treatment, Xofluza from pharmaceutical maker Shionogi, last week. It could soon prove to be a significant competitor to Swiss drug giant Roche’s Tamiflu, one of the most common antivirals used to treat the flu. But it could also take until at least 2019 for Xofluza to reach the U.S. market.
Read more: http://fortune.com/2018/02/23/japan-shionogi-flu-drug-kills-virus-one-day/?source=Snapzu
No comments:
Post a Comment